Addition of indole to methyl 2-chloro-2-cyclopropylideneacetate en route to spirocyclopropanated analogues of demethoxyfumitremorgine C and tadalafil

European Journal of Organic Chemistry

Volumn , Issue 3, 2005, Pages 610-617

  Limbach, Michael ^a   Dalai, Suryakanta ^a   Janssen, André ^a   Es Sayed, Mazen ^b   Magull, Jörg ^a   De Meijere, Armin ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b BAYER CROPSCIENCE AG   (Germany)

Author keywords

Building blocks; Heterocycles; Natural products; Peptidomimetics; Small ring systems

Indexed keywords

CYCLOPROPANE; DEMETHOXYFUMITREMORGINE C; INDOLE DERIVATIVE; LEWIS ACID; NATURAL PRODUCT; SPIRO COMPOUND; SPIROCYCLOPROPANE; TADALAFIL; TRYPTOPHAN DERIVATIVE; UNCLASSIFIED DRUG;

ADDITION REACTION; ANALYTIC METHOD; ARTICLE; CATALYSIS; CHEMICAL ANALYSIS; CONFORMATIONAL TRANSITION; CYCLOPROPANATION; DERIVATIZATION; MICHAEL ADDITION; MULTIDRUG RESISTANCE; NEUROTOXICITY; STRUCTURE ANALYSIS;

EID: 14344256966     PISSN: 1434193X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ejoc.200400617     Document Type: Article

References (50)

1. [1a] p López-Alvarado, S. García-Granda, C. Álvarez-Rúa, C. Avendaño, Eur. J. Org. Chem. 2002, 1702-1707.
2. [1b] P. M. T. Ferreira, H. L. S. Maia, L. S. Monteiro, J. Sacramento, J. Sebastião, J. Chem. Soc., Perkin Trans. 1 2000, 3317-3324.
3. [1c] J. H. Poupaert, J. Bukuru, A. Gozzo, Monatsh. Chem. 1999, 130, 929-932.
4. [1d] M.-F. Hsieh, P. D. Rao, C.-C. Liao, Chem. Commun. 1999, 1441-1442.
5. [1e] X.-L. Li, Y.-M. Wang, T. Matsuura, J.-B. Meng, J. Heterocycl. Chem. 1999, 36, 697-701.
6. [1f] S. Peng, E. Winterfeldt, Liebigs Ann. Chem. 1990, 319-322.
7. [1g] P. E. Harrington, M. A. Kerr, Synlett 1996, 1047-1048.
8. [1h] M. Bandini, P. G. Cozzi, M. Giacomini, P. Melchiorre, S. Selva, A. Umani-Ronchi, J. Org. Chem. 2002, 67, 3700-3704.
9. [2a] C. Balsamini, G. Diamantini, A. Duranti, G. Spadoni, A. Tontini, Synthesis 1995, 370-372.
10. [2b] G. Spadoni, C. Balsamini, A. Bedini, E. Duranti, A. Tontini, J. Heterocycl. Chem. 1992, 29, 305-309.
11. [3a] M.-Y. Chang, S.-T. Chen, N.-C. Chang, Heterocycles 2002, 57, 2321-2334.
12. [3b] K. Yamada, F. Yamada, M. Somei, Heterocycles 2002, 57, 1231-1234.
13. [3c] G. Galambos, P. Csókási, C. Szántay Jr., C. Szantay, Liebigs Ann. Recl. 1997, 1969-1978.
14. [3d] G. Galambos, P. Csókási, C. Szántay Jr., G. Czira, C. Szántay, Heterocycles 1994, 38, 1727-1732.
15. [3e] M. Toyota, K. Fukumoto, J. Chem. Soc., Perkin Trans. 1 1992, 547-552.
16. [3f] M. Somei, F. Yamada, H. Ohnishi, Y. Makita, M. Kuriki, Heterocycles 1987, 26, 2823-2828.
17. [3g] E. Ciganek, E. M. Schubert, J. Org. Chem. 1995, 60, 4629-4634.
18. [3h] A.-A. S. El-Ahl, Synth. Commun. 2000, 30, 2223-2231.
19. For a review, see: E. D. Cox, J. M. Cook, Chem. Rev. 1995, 95, 1797-1842.
20. J. Li, T. Wang, P. Yu, A. Peterson, R. Weber, D. Soerens, D. Grubisha, D. Bennett, J. M. Cook, J. Am. Chem. Soc. 1999, 121, 6998-7010.
21. 3), cf. ref.[7c]
22. [7a] C.-B. Cui, H. Kakeya, G. Okada, R. Onose, M. Ubukata, I. Takaheshi, K. Isono, H. Osada, J. Antibiot. 1995, 48, 1382-1384.
23. [17b] C.-B. Cui, H. Kakeya, G. Okada, R. Onose, H. Osada, J. Antibiot. 1996, 49, 527-533.
24. [7c] C.-B. Cui, H. Kakeya, H. Osada, J. Antibiot. 1996, 49, 534-540.
25. [7d] C.-B. Cui, H. Kakeya, H. Osada, J. Antibiot. 1996, 49, 832-835.
26. [7e] C.-B. Cui, H. Kakeya, H. Osada, Tetrahedron 1996, 52, 12651-12666.
27. [7f] C.-B. Cui, H. Kakeya, H. Osada, Tetrahedron 1997, 53, 59-72.
28. S. K. Rabindran, H. He, M. Singh, E. Brown, K. I. Collins, T. Annable, L. M. Greenberger, Cancer Res. 1998, 58, 5850-5858.
29. W. E. Pullman, S. J. Whitaker, A61 K31/4985, 2003; Lilly Icos LLC. Pr.: WO2000US11129, 2000.
30. [10a] M. Limbach, M. Es-Sayed, A. de Meijere, unpublished results.
31. [10b] V. N. Belov, C. Funke, T. Labahn, M. Es-Sayed, A. de Meijere, Eur. J. Org. Chem. 1999, 1345-1356.
32. A. Dougan, P. Grondin, C. Ruault, A.-C. Le Monnier de Gouville, H. Coste, J. Kirilovsky, F. Hyafil, R. Labaudinière, J. Med. Chem. 2003, 46, 4525-4532.
33. A. Dougan, P. Grondin, C. Ruault, A.-C. Le Monnier de Gouville, H. Coste, J. M. Linget, J. Kirilovsky, F. Hyafil, R. Labaudinière, J. Med. Chem. 2003, 46, 4533-4542.
34. [13a] P. D. Bailey, P. J. Cochrane, K. Lorenz, I. P. Collier, D. P. J. Pearson, G. M. Rosair, Tetrahedron Lett. 2001, 42, 113-115.
35. [13b] T. Gan, J. M. Cook, Tetrahedron Lett. 1997, 38, 1301-1304.
36. [13c] K. M. Depew, S. J. Danishefsky, N. Rosen, L. Sepp-Lorenzino, J. Am. Chem. Soc. 1996, 118, 12463-12464.
37. This so-called Thorpe-Ingold effect had originally been attributed to an angle enlargement, see: [14a] R. M. Beesley, C. K. Ingold, J. F. Thorpe, J. Chem. Soc. 1915, 107, 1080-1106.
38. [14b] C. K. Ingold, J. Chem. Soc. 1921, 119, 305.
39. It was later shown that the major influence stems from the conformational preference of such a system, see: [14c] M. E. Jung, M. Kiankarimi, J. Org. Chem. 1998, 63, 2968-2974.
40. [14d] M. E. Jung, J. Gervay, J. Am. Chem. Soc. 1991, 113, 224-232.
41. The corresponding 2-amino-2-[1-(1H-indol-3-yl)cylopropyl]-acetic acid has already been described, see: D. C. Horwell, M. J. McKiernan, S. Osborne, Tetrahedron Lett. 1998, 39, 8729-8732.
42. Problems with the cyclization of prenaldimines have also been observed by others, see: D. M. Harrison, R. B. Sharma, Tetrahedron 1993, 49, 3165-3184.
43. [17a] P. D. Bailey, S. P. Hollinshead, N. R. Mc Lay, K. Morgan, S. J. Palmer, S. N. Prince, C. D. Reynolds, S. D. Wood, J. Chem. Soc., Perkin Trans. 1 1993, 431-439.
44. [17b] P. D. Bailey, M. H. Moore, K. M. Morgan, D. I. Smith, J. M. Vernon, Tetrahedron Lett. 1994, 35, 3587-3588.
45. [17c] H. Wang, A. Ganesan. Tetrahedron Lett. 1997, 38, 4327-4328.
46. L. A. Carpino, B. J. Cohen, K. E. Stephens Jr., S. Y. Sadat-Aalaee, J.-H. Tien, D. C. Langridge, J. Org. Chem. 1986, 51, 3732-3734.
47. On the basis of the known absolute configuration of the employed (S)-proline and the assumption that it did not racemize during incorporation, this depicts the overall absolute configuration as well.
48. [20a] T. Liese, F. Seyed-Mahdavi, A. de Meijere, Org. Synth. 1990, 69, 148-153.
49. [20b] For an advanced synthesis of 4 see: M. Limbach, S. Dalai, A. de Meijere, Adv. Synth. Catal. 2004, 346, 760-766.
50. 2 (310.4): calcd. C 73.52, H 7.14, N 9.03; found C 73.19, H 7.15, N 8.91.